PMS-PAZOPANIB

Identification of Pms-Pazopanib

No description

Google image searchProduct monograph

Active ingredient

pazopanib (pazopanib hydrochloride), 200 MG

DIN: 02525666

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: PHARMASCIENCE INC

Date: 31-AUG-2022

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
• L01EX03 — PAZOPANIB (ATC/DDD)

Reference brand drug: Votrient

External Links for Pms-Pazopanib

Search on Google

• Pms-Pazopanib side effects
• Pms-Pazopanib dosage
• pazopanib side effects
• pazopanib dosage

Pharmascience Inc

Go to Pharmascience website to see drug product details. Sometimes you can find pms-pazopanib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.